Stock ARAB PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Arab Pharmaceuticals Share Price Egyptian Exchange

Equities

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
- EGP - Intraday chart for Arab Pharmaceuticals
02-14 The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Financials

Sales 2022 505M 10.7M 839M Sales 2023 634M 13.42M 1.05B Capitalization 401M 8.49M 666M
Net income 2022 76M 1.61M 126M Net income 2023 82M 1.74M 136M EV / Sales 2022 0.76 x
Net Debt 2022 111M 2.35M 184M Net Debt 2023 142M 3M 235M EV / Sales 2023 0.86 x
P/E ratio 2022
4.07 x
P/E ratio 2023
5.64 x
Employees -
Yield 2022 *
-
Yield 2023
6.73%
Free-Float 25.15%
More Fundamentals * Assessed data

Latest news about Arab Pharmaceuticals

The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
The Arab Drug Company Reports Earnings Results for the Half Year Ended December 31, 2021 CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2021 CI
The Arab Drug Company Reports Financial Results for the Period from July 1, 2020 to March 31, 2021 CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2020 CI
The Arab Drug Company Announces Unaudited Earnings Results for the Full Year Ended June 30, 2020 CI
The Arab Drug Company Reports its Financial Results for the Period from July 1, 2019 to March 31, 2020 CI
Arab Drug Company Announces Earnings Results for the Nine Months Ended 31 March 2020 CI
The Arab Drug Company Reports Its Financial Results for the Period from July 1, 2019 to September 30, 2019 CI
Arab Pharmaceuticals Announces Earnings Results for the Quarter Ended March 31, 2019 CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018 CI
Arab Pharmaceuticals Reports Earnings Results for the Quarter Ended September 30, 2018 CI
More news

Press releases Arab Pharmaceuticals

Arab Drug : Pharmaceuticals (ADCI.CA) Reports 6 Months Results PU
More press releases

Managers and Directors - Arab Pharmaceuticals

Managers TitleAgeSince
Tamer Mohamed Ahmed El Hosseiny CEO
 Chief Executive Officer - -
Ossama Mustafa Abdel Baset CEO
 Chief Executive Officer - -
Tariq Ali DFI
 Director of Finance/CFO - -
Members of the board TitleAgeSince
Muhsin Mohammed Omar El-Nadi IRC
 Investor Relations Contact - -
Ossama Mustafa Abdel Baset CEO
 Chief Executive Officer - -
Mahmoud Abbas Hamdi CHM
 Chairman - -
More insiders

Company Profile

Arab Drug Company for Pharmaceuticals and Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical and veterinary products.
Sector
Pharmaceuticals
More about the company

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ADCI Stock
  4. Stock